MicroRNAs and target genes in epileptogenesis

Area of Science:

• Neuroscience
• Molecular Biology
• Genetics

Background:

• Epilepsy is a chronic brain disorder characterized by recurrent seizures.
• Current antiepileptic drugs do not prevent epileptogenesis, the underlying process of epilepsy development.
• MicroRNAs (miRNAs) are increasingly recognized as key regulators of gene expression implicated in epilepsy.

Purpose of the Study:

• To review the role of microRNAs (miRNAs) in epileptogenesis.
• To explore the potential of miRNAs as therapeutic targets for epilepsy treatment.
• To identify specific miRNAs and their validated targets involved in epilepsy.

Main Methods:

• A systematic literature search was conducted on PubMed using keywords related to miRNAs and epilepsy.
• Articles were selected based on validated miRNA-target gene interactions and in vivo evidence of miRNA manipulation affecting epileptogenesis.
• A total of 13 miRNAs were identified and analyzed.

Main Results:

• Alterations in specific miRNAs are observed in epileptic hippocampi of experimental models and human tissues.
• Manipulation of miRNAs in animal models can influence epileptogenesis during the chronic phase.
• Transgenic mice overexpressing miR-211 or miR-128 exhibited seizure phenotypes, indicating their critical role.

Conclusions:

• MicroRNAs represent promising targets for preventing epileptogenesis and developing novel epilepsy therapies.
• While individual miRNAs have limitations as targets, understanding their regulatory networks is crucial.
• Further research into miRNA-based strategies could lead to effective epilepsy cures.